对《关于Neiser等人用酶联免疫吸附测定法（ELISA）评估静脉铁制剂的右旋糖酐抗原性。国际分子科学杂志2016年，第17卷，第1185页》的评论的回复
Reply to "Comment on Neiser et al. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Int. J. Mol. Sci. 2016, 17, 1185.".
作者信息
Burckhardt Susanna
机构信息
Global Medical Affairs, Vifor Pharma Ltd., 8152 Glattbrugg, Switzerland.
出版信息
Int J Mol Sci. 2017 Jan 10;18(1):122. doi: 10.3390/ijms18010122.
Abstract
n/a.
摘要
无可用信息。
相似文献
1
Reply to "Comment on Neiser et al. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Int. J. Mol. Sci. 2016, 17, 1185.".对《关于Neiser等人用酶联免疫吸附测定法（ELISA）评估静脉铁制剂的右旋糖酐抗原性。国际分子科学杂志2016年，第17卷，第1185页》的评论的回复
Int J Mol Sci. 2017 Jan 10;18(1):122. doi: 10.3390/ijms18010122.
2
Comment on Neiser et al. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Int. J. Mol. Sci. 2016, 17, 1185.关于奈泽尔等人。用酶联免疫吸附测定法（ELISA）评估静脉注射铁制剂的右旋糖酐抗原性。《国际分子科学杂志》2016年，第17卷，第1185页。
Int J Mol Sci. 2017 Jan 10;18(1):121. doi: 10.3390/ijms18010121.
3
Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA).用酶联免疫吸附测定法（ELISA）评估静脉铁制剂的右旋糖酐抗原性。
Int J Mol Sci. 2016 Jul 21;17(7):1185. doi: 10.3390/ijms17071185.
4
Iron availability and complex stability of iron hydroxyethyl starch and iron dextran a comparative in vitro study with liver cells and macrophages.
Nephrol Dial Transplant. 2007 Oct;22(10):2824-30. doi: 10.1093/ndt/gfm315. Epub 2007 Jun 7.
5
Anti-dextran antibodies of carp detected by the enzyme-linked immunosorbent assay (ELISA).通过酶联免疫吸附测定（ELISA）检测鲤鱼的抗葡聚糖抗体。
Allerg Immunol (Leipz). 1988;34(4):269-73.
6
Preparation and Characteristic of Dextran-BSA Antibody and Establishment of its ELISA Immunoassay.葡聚糖-牛血清白蛋白抗体的制备、特性及其酶联免疫吸附测定法的建立
J Immunoassay Immunochem. 2015;36(6):597-612. doi: 10.1080/15321819.2015.1027403.
7
C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI.C-MALISA（细胞磁联免疫吸附测定法），一种用于磁共振成像的细胞酶联免疫吸附测定法的新应用。
J Inorg Biochem. 2005 May;99(5):1135-44. doi: 10.1016/j.jinorgbio.2005.02.009.
8
Reply to Sheval, E.V. Comment on "Piña et al. Ten Approaches That Improve Immunostaining: A Review of the Latest Advances for the Optimization of Immunofluorescence. 2022, , 1426".回复 Sheval, E.V. 对“Piña 等人的评论。改善免疫染色的十种方法：对免疫荧光优化的最新进展综述。2022，，1426”。
Int J Mol Sci. 2022 Apr 15;23(8):4375. doi: 10.3390/ijms23084375.
9
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.用改良 ELISA 检测血清铁调素与骨髓增生异常综合征患者铁代谢参数相关。
Ann Hematol. 2013 Dec;92(12):1617-23. doi: 10.1007/s00277-013-1839-5. Epub 2013 Jul 11.
10
Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. 2022, , 2140.更正：芬克等人。静脉注射铁-碳水化合物纳米颗粒复合物表面特性的关键性：对药代动力学和药效学的影响。2022年，，2140。 （注：原文中“2022, , 2140”表述似乎不完整或有误）
Int J Mol Sci. 2022 Sep 6;23(18):10230. doi: 10.3390/ijms231810230.
本文引用的文献
1
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions.不同静脉注射铁剂后的药物特异性低磷血症和过敏反应。
Br J Clin Pharmacol. 2017 May;83(5):1118-1125. doi: 10.1111/bcp.13189. Epub 2017 Jan 18.
2
Safety of intravenous iron use in chronic kidney disease.慢性肾脏病患者静脉补铁的安全性
Curr Opin Nephrol Hypertens. 2016 Nov;25(6):529-535. doi: 10.1097/MNH.0000000000000263.
3
Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA).用酶联免疫吸附测定法（ELISA）评估静脉铁制剂的右旋糖酐抗原性。
Int J Mol Sci. 2016 Jul 21;17(7):1185. doi: 10.3390/ijms17071185.
4
Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience.介绍异麦芽糖酐铁1000（莫诺菲®）——研发原理与临床经验。
NDT Plus. 2011 Jun;4(Suppl 1):i10-i13. doi: 10.1093/ndtplus/sfr042.
5
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.静脉铁剂相关过敏反应的比较风险。
JAMA. 2015 Nov 17;314(19):2062-8. doi: 10.1001/jama.2015.15572.
6
Safety of intravenous iron formulations: facts and folklore.静脉铁制剂的安全性：事实与传闻
Blood Transfus. 2014 Jul;12(3):296-300. doi: 10.2450/2014.0094-14.
7
A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.一项关于静脉用铁剂新型制剂异麦芽糖酐铁 1000（Monofer）理化性质的对比研究及其临床意义。
Eur J Pharm Biopharm. 2011 Aug;78(3):480-91. doi: 10.1016/j.ejpb.2011.03.016. Epub 2011 Mar 23.
8
High-molecular weight iron dextran: a wolf in sheep's clothing?高分子量右旋糖酐铁：披着羊皮的狼？
J Am Soc Nephrol. 2008 May;19(5):833-4. doi: 10.1681/ASN.2008030255. Epub 2008 Mar 27.
9
Anaphylaxis due to hydroxyethyl-starch-reactive antibodies.由羟乙基淀粉反应性抗体引起的过敏反应。
Lancet. 1995 Jul 1;346(8966):49-50. doi: 10.1016/s0140-6736(95)92677-1.
Zotero 插件